Cultured porcine coronary artery smooth muscle cells: A new model with advanced differentiation

Circulation Research

Volumn 85, Issue 1, 1999, Pages 99-107

  Christen, Thomas ^a   Bochaton Piallat, Marie Luce ^a   Neuville, Pascal ^c   Rensen, Sander ^b   Redard, Mireille ^a   Van Eys, Guillaume ^b   Gabbiani, Giulio ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c TRANSGENE S A   (France)

Author keywords

Actin; Atheromatosis; Myosin; Restenosis; Smoothelin

Indexed keywords

ACTIN; DESMIN; HEPARIN; MYOSIN HEAVY CHAIN; RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL CELL; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROMATOSIS; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CORONARY ARTERY; ENDOTHELIUM INJURY; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; SMOOTH MUSCLE FIBER;

EID: 0033538614     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.85.1.99     Document Type: Article

References (58)

1. Schwartz SM, O'Brien ER, de Blois D, Giachelli CM. Relevance of smooth muscle replication and development to vascular disease. In: Schwartz SM, Mecham RP, eds. The Vascular Smooth Muscle Cell. Molecular and Biological Responses to the Extracellular Matrix. San Diego, Calif: Academic Press Inc; 1995:81-140.
2. Kocher O, Gabbiani G. Expression of actin mRNAs in rat aortic smooth muscle cells during development, experimental thickening, and culture. Differentiation. 1986;32:245-251.
3. Skalli O, Bloom WS. Ropraz P, Azzarone B, Gabbiani G. Cytoskeletal remodeling of rat aortic smooth muscle cells in vitro: relationships to culture conditions and analogies to in vivo situations. J Submicrosc Cytol. 1986;18:481-493.
4. Campbell JH, Kocher O, Skalli O, Gabbiani G, Campbell GR. Cytodifferentiation and expression of α-smooth muscle actin mRNA and protein during primary culture of aortic smooth muscle cells. Correlation with cell density and proliferative state. Arteriosclerosis. 1989;9:633-643.
5. Thyberg J, Hedin U, Sjölund M, Palmberg L. Bottger BA. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis. 1990;10:996-990.
6. Bochaton-Piallat M-L, Gabbiani F, Ropraz P, Gabbiani G. Cultured aortic smooth muscle cells from newborn and adult rats show distinct cytoskeletal features. Differentiation. 1992;49:175-185.
7. Birukov KG, Frid MG, Rogers JD, Shirinsky VP, Koteliansky VE, Campbell JH, Campbell GR. Synthesis and expression of smooth muscle phenotype markers in primary culture of rabbit aortic smooth muscle cells: influence of seeding density and media and relation to cell contractility. Exp Cell Res. 1993;204:46-53.
8. Schwartz RS, Edwards WD, Huber KC, Antoniades LC, Bailey KR, Camrud AR, Jorgenson MA, Holmes DR. Coronary restenosis: prospects 1 for solution and new perspectives from a porcine model. Mayo Clin Proc. 1993;68:54-62.
9. Zalewski A, Shi Y. Vascular myofibroblasts. Lessons from coronary repair and remodeling. Arterioscler Thromb Vasc Biol. 1997;17:417-422.
10. Gal D, Rongione AJ, Slovenkai GA, DeJesus ST, Lucas A, Fields CD, Isner JM. Atherosclerotic Yucatan microswine: an animal model with high-grade, fibrocalcific, nonfatty lesions suitable for testing catheter-based interventions. Am Heart J. 1990;119:291-300.
11. Grinstead WC, Rodgers GP, Mazur W, French BA, Cromeens D, Van Pelt C, West SM, Raizner AE. Comparison of three porcine restenosis models: the relative importance of hypercholesterolemia endothelial abrasion, and stenting. Coron Artery Dis. 1994;5:425-434.
12. Bochaton-Piallat M-L, Ropraz P, Gabbiani F, Gabbiani G. Phenotypic heterogeneity of rat arterial smooth muscle cell clones. Implications for the development of experimental intimai thickening. Arterioscler Thromb Vasc Biol. 1996;16:815-820.
13. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G. A monoclonal antibody against a-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol. 1986;103:2787-2796.
14. Benzonana G, Skalli O, Gabbiani G. Correlation between the distribution of smooth muscle or nonmuscle myosins and α-smooth muscle actin in normal and pathological soft tissues. Cell Motil Cytoskeleton. 1988;11: 260-274.
15. van der Loop FT, Schaart G, Timmer ED, Ramaekers FCS, van Eys GJ. Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells. J Cell Biol. 1996;134:401-411.
16. 1. J Cell Biol. 1998; 142:873-881.
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
18. Hirschi KK, Rohovsky SA, D'Amore PA. PDGF, TGf-β, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol. 1998;141:805-814.
19. Ponte P, Gunning P, Blau H, Kedes L. Human actin genes are single copy for α-skeletal and α-cardiac actin but multicopy for β-cytoskeletal genes: 3′ untranslated regions are isotype specific but are conserved in evolution. Mol Cell Biol. 1983;3:1783-1791.
20. Kocher O, Gabbiani G. Analysis of α-smooth-muscle actin mRNA expression in rat aortic smooth-muscle cells using a specific cDNA probe. Differentiation. 1987;34:201-209.
21. van der Loop FTL, Gabbiani G, Kohnen G, Ramaekers FCS, van Eys GJJM. Differentiation of smooth muscle cells in human blood vessels as defined by smoothelin, a novel marker for the contractile phenotype. Arterioscler Thromb Vasc Biol. 1997;17:665-671.
22. van Eys GJJM, Völler MCW, Timmer EDJ, Wehrens XHT, Small JV, Schalken JA, Ramaekers FCS, van der Loop FTL. Smoothelin expression characteristics: development of a smooth muscle cell in vitro system and identification of a vascular variant. Cell Struct Funct. 1997;22:65-72.
23. Barja F, Coughlin C, Belin D, Gabbiani G. Actin isoform synthesis and mRNA levels in quiescent and proliferating rat aortic smooth muscle cells in vivo and in vitro. Lab Invest. 1986;55:226-233.
24. Rovner AS, Murphy RA, Owens GK. Expression of smooth muscle and nonmuscle myosin heavy chains in cultured vascular smooth muscle cells. J Biol Chem. 1986;261:14740-14745.
25. Babij P, Kawamoto S, White S, Adelstein RS, Periasamy M. Differential expression of SM1 and SM2 myosin isoforms in cultured vascular smooth muscle. Am J Physiol. 1992;262:C607-C613.
26. Sartore S, Chiavegato A, Franch R, Faggin E, Pauletto P. Myosin gene expression and cell phenotypes in vascular smooth muscle during development, in experimental models, and in vascular disease. Arterioscler Thromb Vasc Biol. 1997;17:1210-1215.
27. Low RB, White SL. Lung smooth muscle differentiation. Int J Biochem Cell Biol. 1998;30:869-883.
28. Owens GK, Loeb A, Gordon D, Thompson MM. Expression of smooth muscle-specific α-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation. J Cell Biol. 1986; 102:343-352.
29. Clowes AW, Clowes MM. Kinetics of cellular proliferation after arterial injury, II: inhibition of smooth muscle growth by heparin. Lab Invest. 1985;52:611-616.
30. Desmoulière A, Rubbia-Brandt L, Gabbiani G. Modulation of actin isoform expression in cultured arterial smooth muscle cells by heparin and culture conditions. Arterioscler Thromb. 1991;11:244-253.
31. 1 on human arterial smooth muscle cells in vitro. Arterioscler Thromb. 1991;11:892-902.
32. 1 and heparin. Exp Cell Res. 1994;214:528-536.
33. Neuville P, Geinoz A, Benzonana G, Redard M, Gabbiani F, Ropraz P, Gabbiani G. Cellular retinol-binding protein I is expressed by distinct subsets of rat arterial smooth muscle cells in vitro and in vivo. Am J Pathol. 1997;150:509-521.
34. Schwartz RS, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, Holmes DR. Restenosis after balloon angioplasty: a practical proliferative model in porcine coronary arteries. Circulation. 1990;82:2190-2200.
35. Muller DW, Ellis SG, Topol EJ. Experimental models of coronary artery restenosis [erratum appears in J Am Coll Cardiol. 1992;19:1678]. J Am Coll Cardiol. 1992;19:418-432.
36. Fager G, Hansson GK, Gown AM, Larson DM, Skalli O, Bondjers G. Human arterial smooth muscle cells in culture: inverse relationship between proliferation and expression of contractile proteins. In Vitro Cell Dev Biol. 1989;25:511-520.
37. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 1995;75:487-517.
38. Gabbiani 3G, Schmid E, Winter S, Chaponnier C, de Chastonay C, Vanderkerckhove J, Weber K, Franke WW. Vascular smooth muscle cells differ from other smooth muscle cells: predominance of vimentin filaments and a specific α-type actin. Proc Natl Acad Sci U S A. 1981;78: 298-302.
39. Borrione AC, Zanellato AMC, Scannapieco G, Pauletto P, Sartore S. Myosin heavy-chain isoforms in adult and developing rabbit vascular smooth muscle. Eur J Biochem. 1989;183:413-417.
40. Bochaton-Piallat M-L, Gabbiani F, Ropraz P, Gabbiani G. Age influences the replicative activity and the differentiation features of cultured rat aortic smooth muscle cell populations and clones. Arterioscler Thromb. 1993;13:1449-1455.
41. Wehrens XHT, Mies B, Gimona M, Ramaekers FCS, van Eys GJJM, Small JV. Localization of smoothelin in avian smooth muscle and identification of a vascular-specific isoform. FEBS Lett. 1997;405:315-320.
42. Chamley-Campbell JH, Campbell GR. What controls smooth muscle phenotype? Atherosclerosis. 1981;40:347-357.
43. Castellot JJ, Favreau LV, Karnovsky MJ, Rosenberg RD. Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidase. J Biol Chem. 1982;257: 11256-11260.
44. Weissberg PL, Grainger DJ, Shanahan CM, Metcalfe JC. Approaches to the development of selective inhibitors of vascular smooth muscle cell proliferation. Cardiovasc Res. 1993;27:1191-1198.
45. Kohno M, Yokokawa K, Yasunari K, Minami M, Kano H, Mandal AK, Yoshikawa J. Heparin inhibits human coronary artery smooth muscle cell migration. Metabolism. 1998;47:1065-1069.
46. Koyama N, Kinsella MG, Wight TN, Hedin U, Clowes AW. Heparan sulfate proteoglycans mediate a potent inhibitory signal for migration of vascular smooth muscle cells. Circ Res. 1998;83:305-313.
47. Majack RA, Goodman LV, Dixit VM. Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation. J Cell Biol. 1988;106:415-422.
48. Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R. TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell. 1991;63:515-524.
49. 1 is a powerful modulator of platelet-derived growth factor action in vascular smooth muscle cells. J Cell Physiol. 1992;150:232-242.
50. Hautmann MB, Madsen CS, Owens GK. A transforming growth factor ß (TGFβ) control element drives TGFβ-induced stimulation of smooth muscle α-actin gene expression in concert with two CArG elements. J Biol Chem. 1997;272:10948-10956.
51. Blank RS, Swartz EA, Thompson MM, Olson EN, Owens GK. A retinoic acid-induced clonal cell line derived from multipotential P19 embryonal carcinoma cells expresses smooth muscle characteristics. Circ Res. 1995; 76:742-749.
52. Colbert MC, Kirby ML, Robbins J. Endogenous retinoic acid signaling colocalizes with advanced expression of the adult smooth muscle myosin heavy chain isoform during development of the ductus arteriosus. Circ Res. 1996;78:790-798.
53. Gollasch M, Haase H, Ried C, Lindschau C, Morano I, Luft FC, Haller H. L-type calcium channel expression depends on the differentiated state of vascular smooth muscle cells. FASEB J. 1998;12:593-601.
54. Miano JM, Topouzis S, Majesky MW, Olson EN. Retinoid receptor expression and all-trans retinoic acid-medialed growth inhibition in vascular smooth muscle cells. Circulation. 1996;93:1886-1895.
55. Chen SC, Gardner DG. Retinoic acid uses divergent mechanisms to activate or suppress mitogenesis in rat aortic smooth muscle cells. J Clin Invest. 1998;102:653-662.
56. Neuville P, Yan ZQ, Gidlöf A, Pepper MS, Hansson GK, Gabbiani G, Sirsjö A. Retinoic acid regulates arterial smooth muscle cell proliferation and phenotypic features in vivo and in vitro through an RARα-dependent-signaling pathway. Arterioscler Thromb Vasc Biol. 1999;19:1430-1436.
57. Miano JM, Kelly LA, Artacho CA, Nuckolls TA, Piantedosi R, Blaner WS. all-Trans-retinoic acid reduces neointimal formation and promotes favorable geometric remodeling of the rat carotid artery after balloon withdrawal injury. Circulation. 1998;98:1219-1227.
58. Bochaton-Piallat ML, Gabbiani G, Pepper MS. Plasminogen activator expression in rat arterial smooth muscle cells depends on their phenotype and is modulated by cytokines. Circ Res. 1998;82:1086-1093.